Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OncoSec Medical Inc

+ Add to Watchlist

ONCS:US

0.3100 USD 0.0050 1.59%

As of 20:10:05 ET on 04/17/2015.

Snapshot for OncoSec Medical Inc (ONCS)

Open: 0.3135 Day's Range: 0.3050 - 0.3200 Volume: 1,768,644
Previous Close: 0.3150 52wk Range: 0.3050 - 0.9000 1-Yr Rtn: -56.94%

Stock Chart for ONCS

No chart data available.
  • ONCS:US 0.3100
  • 1D
  • 1M
  • 1Y
0.3150
Interactive ONCS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ONCS

Current P/E Ratio (ttm) -
Estimated P/E(07/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.0800
Est. EPS (USD) (07/2015) -0.0700
Est. PEG Ratio -
Market Cap (M USD) 76.57
Shares Outstanding (M) 247.00
30 Day Average Volume 1,214,315
Price/Book (mrq) 2.4525
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ONCS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ONCS

OncoSec Medical Inc. provides biomedical services. The Company focuses on commercializing therapeutic oncology products. OncoSec Medical offers patients with alternative treatments to existing therapies to treat cancerous tumors and cancerous cells.

Punit S DhillonPresident/CEO/Co-FounderVeronica VallejoChief Financial Officer
Adil DaudChief Clinical StrategistMai H LeChief Medical Officer
More Company Profile & Key Executives for ONCS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil